Makoto Inada

Makoto Inada

Auto-generated profile, based on publicly available information

Makoto Inada

Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2020 in Internal Medicine
Verified
Journal Article
Open access
PDF file
SISatoshi Ide
Satoshi Ide
SMShinichiro Morioka
Shinichiro Morioka
MIMakoto Inada
Makoto Inada
NONorio Ohmagari
Norio Ohmagari
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 July 2021 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
MIMakoto Inada
Makoto Inada
MIMasahiro Ishikane
Masahiro Ishikane
MTMari Terada
Mari Terada
AMAkihiro Matsunaga
Akihiro Matsunaga
KMKenji Maeda
Kenji Maeda
NONorio Ohmagari
Norio Ohmagari

20 October 2021 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
AOAyako Okuhama
Ayako Okuhama
MHMasatoshi Hotta
Masatoshi Hotta
MIMasahiro Ishikane
Masahiro Ishikane
AKAkira Kawashima
Akira Kawashima
YMYusuke Miyazato
Yusuke Miyazato
NONorio Ohmagari
Norio Ohmagari

27 August 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
MIMakoto Inada
Makoto Inada
NKNoriko Kinoshita
Noriko Kinoshita
HNHidetoshi Nomoto
Hidetoshi Nomoto
STShinya Tsuzuki
Shinya Tsuzuki
NTNorihiko Takemoto
Norihiko Takemoto
NONorio Ohmagari
Norio Ohmagari
Streptococcal toxic shock syndrome (STSS) is a life-threatening condition caused by beta-hemolytic streptococci (BHS). Streptococcus pyogenes is the main causative agent of this disease; other BHS such as S. agalactiae or S. dysgalactiae could also cause STSS. However, the clinical characteristics of STSS caused by other types of BHS remain poorly understood. In this study, we evaluated the likelihood of STSS development in various streptococcal species. We conducted a retrospective observational study using adult medical records of patients with invasive BHS in a tertiary care institution from 2002–2022 and classified them into STSS or non-STSS groups. Multivariable analysis of bacterial species adjusted for age and diabetes mellitus was conducted. S. pyogenes cases were propensity-matched (1:4) to non-pyogenes BHS cases. A total of 43 STSS and 285 non-STSS cases were identified. S. pyogenes, S. agalactiae, and S. dysgalactiae accounted for 17, 13, and 13 STSS cases, respectively. The crude mortality of STSS was approximately 35% in all groups. A multivariable analysis suggested that STSS was less frequent in S. agalactiae and S. dysgalactiae cases with odds ratio 0.24 (95% confident interval [CI]: 0.10–0.54, p<0.001) and 0.23 (95% CI: 0.10–0.55, p<0.001), respectively. Propensity score matching showed that S. pyogenes caused STSS more frequently than other BHS cases with an odds ratio of 3.28 (95% CI: 1.21–8.77, p=0.010). This study described and compared the clinical characteristics of STSS caused by different BHS. We demonstrated that S. pyogenes caused STSS more often than other BHS.

1 January 2000 in Japanese Journal of Phytopathology
Verified
Journal Article
Open access
JYJ. Yamaguchi
J. Yamaguchi
MIM. Inada
M. Inada
MMM. Matsuzaki
M. Matsuzaki

4 May 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
TSTetsuya Suzuki
Tetsuya Suzuki
SKSatoshi Kutsuna
Satoshi Kutsuna
SSSho Saito
Sho Saito
AKAkira Kawashima
Akira Kawashima
AOAyako Okuhama
Ayako Okuhama
NONorio Ohmagari
Norio Ohmagari